Plasma amine oxidase and genetic vulnerability to schizophrenia

Area of Science:

• Biochemistry
• Genetics
• Psychiatry

Background:

• Schizophrenia is a complex psychiatric disorder with potential biological underpinnings.
• Enzyme activity, such as plasma amine oxidase (PAO), is being investigated as a potential biomarker.

Purpose of the Study:

• To investigate plasma amine oxidase (PAO) activity in chronic schizophrenic patients, their relatives, and healthy controls.
• To determine if PAO activity is a heritable and stable characteristic.
• To explore the association between PAO activity and schizophrenia spectrum disorders.

Main Methods:

• Enzyme activity assays were performed on plasma samples.
• Subjects included 52 chronic schizophrenics, 130 first-degree relatives, and 36 normal controls.
• Statistical analyses were used to assess heritability, stability, and group differences.

Main Results:

• Plasma amine oxidase (PAO) activity was found to be a heritable and stable trait.
• No significant effects of age or sex on PAO activity were observed.
• Patients with schizophrenia exhibited lower PAO activity than controls, though not statistically significant.
• Reduced PAO activity was associated with schizophrenia spectrum disorders within families.

Conclusions:

• Plasma amine oxidase (PAO) activity is a stable, heritable characteristic.
• Lower PAO activity may be associated with schizophrenia spectrum disorders.
• Further research is needed to clarify the role of PAO in schizophrenia pathogenesis.